Study guide

PCOS diagnosis and long-term care

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

PCOS diagnosis and long-term care

Key Takeaways Explain This Topic AI

Adults need two of the three diagnostic features after excluding other causes.

Adolescent PCOS requires both ovulatory dysfunction and hyperandrogenism; ultrasound is not recommended for diagnosis.

Continuous progestin-associated amenorrhoea is not the same as untreated anovulation.

Last updated: October 2026

Rotterdam Diagnostic Criteria

Diagnosis requires the presence of at least 2 out of the following 3 features (after excluding mimickers including thyroid disease, hyperprolactinaemia, and non-classic congenital adrenal hyperplasia via serum 17-hydroxyprogesterone):

Oligo- or Anovulation : Manifesting as menstrual cycles > 35 days > 35\text{ days} > 35 days apart or < 8 cycles per year < 8\text{ cycles per year} < 8 cycles per year .

Clinical or Biochemical Hyperandrogenism :

Clinical : Hirsutism evaluated using the modified Ferriman-Gallwey score (score ≥ 4 to 6 \ge 4\text{ to }6 ≥ 4 to 6 depending on ethnicity), moderate-to-severe inflammatory acne, or female-pattern androgenic alopecia.

Biochemical : Elevated serum total or calculated free testosterone, elevated Free Androgen Index ( F A I = [ Total Testosterone (nmol/L) / SHBG (nmol/L) ] × 100 > 4.5 FAI = [\text{Total Testosterone (nmol/L)} / \text{SHBG (nmol/L)}] \times 100 > 4.5 F A I = [ Total Testosterone (nmol/L) / SHBG (nmol/L) ] × 100 > 4.5 ), or elevated dehydroepiandrosterone sulphate (DHEAS).

Polycystic Ovarian Morphology (PCOM) on Ultrasound :

Presence of ≥ 20 follicles per ovary \ge 20\text{ follicles per ovary} ≥ 20 follicles per ovary measuring 2 to 9 mm 2\text{ to }9\text{ mm} 2 to 9 mm in diameter, and/or an increased ovarian volume ≥ 10 mL \ge 10\text{ mL} ≥ 10 mL in either ovary (using transvaginal transducers ≥ 8 MHz \ge 8\text{ MHz} ≥ 8 MHz , excluding dominant follicles or corpus luteum). Pelvic ultrasound should not be used for diagnosis within 8 years of menarche due to the high frequency of multi-follicular ovaries in normal post-menarchal adolescence.

Long-Term Health Complications

Insulin Resistance & Type 2 Diabetes : Intrinsic post-receptor insulin signalling defects lead to compensatory hyperinsulinaemia. Insulin acts synergistically with luteinizing hormone (LH) on ovarian theca cells to drive androgen synthesis and suppresses hepatic production of sex hormone-binding globulin (SHBG), augmenting free circulating testosterone. All women with PCOS require a baseline 75 g 2-hour oral glucose tolerance test (OGTT) .

Cardiovascular Disease & Metabolic Syndrome : High prevalence of atherogenic dyslipidaemia (elevated triglycerides, low HDL, elevated small dense LDL) and hypertension.

Endometrial protection in PCOS: Address prolonged unopposed oestrogen with a suitable progestogen strategy. Cyclic withdrawal bleeding is one option; continuous progestogen or an LNG-IUD may provide protection with amenorrhoea. Four bleeds per year are not mandatory when the endometrium is already protected.

Therapeutic Principles

Lifestyle Intervention : The cornerstone of therapy. A modest weight reduction of 5% to 10% of total body weight improves insulin sensitivity, lowers circulating androgens, restores spontaneous ovulatory cycles, and enhances fertility.

Metformin : An oral biguanide ( 1000 to 2000 mg 1000\text{ to }2000\text{ mg} 1000 to 2000 mg daily in divided doses) that improves peripheral insulin sensitivity, reduces hyperinsulinaemia, promotes modest weight loss, and improves menstrual cyclicity.

Combined Oral Contraceptive Pills : First-line pharmacological management for hirsutism and irregular menses in women not seeking immediate conception. Oestrogen suppresses pituitary LH secretion and stimulates hepatic SHBG production, reducing bioavailable free testosterone, while the progestogen protects the endometrium against hyperplasia.

Anti-Androgens : Spironolactone ( 50 to 200 mg 50\text{ to }200\text{ mg} 50 to 200 mg daily) or cyproterone acetate competitively blocks androgen receptors. Must always be co-prescribed with effective contraception due to the risk of feminization of a male fetus.

Ovulation Induction for Subfertility : Letrozole (an oral aromatase inhibitor, 2.5 to 7.5 mg 2.5\text{ to }7.5\text{ mg} 2.5 to 7.5 mg daily on cycle days 3 to 7) is the first-line agent of choice , achieving significantly higher ovulation and live birth rates than clomiphene citrate with a lower risk of multiple gestations. Second-line treatments include low-dose exogenous gonadotrophins and laparoscopic ovarian drilling.

Clinical comparison: FIGO PALM-COEIN Classification, Diagnostic Features & Interventions

Polyp : FIGO Code: AUB-P; Distinguishing Pathophysiological / Imaging Hallmark: Intracavitary focal overgrowth with solitary feeding vascular pedicle on Doppler; First-Line Investigation: Transvaginal ultrasound / Saline infusion sonography; Primary Clinical Management: Hysteroscopic polypectomy with histological examination

Leiomyoma : FIGO Code: AUB-L; Distinguishing Pathophysiological / Imaging Hallmark: Monoclonal myometrial smooth muscle tumour; submucosal (Types 0–2) causes severe bleeding; First-Line Investigation: Transvaginal ultrasound / diagnostic hysteroscopy; Primary Clinical Management: Tranexamic acid, LNG-IUD, GnRH analogues; myomectomy or hysterectomy

Coagulopathy : FIGO Code: AUB-C; Distinguishing Pathophysiological / Imaging Hallmark: Systemic haemostatic defect (vWD, thrombocytopenia); menorrhagia since menarche; First-Line Investigation: Coagulation panel, vWF antigen, ristocetin cofactor; Primary Clinical Management: Tranexamic acid, desmopressin, hematology consultation

Ovulatory : FIGO Code: AUB-O; Distinguishing Pathophysiological / Imaging Hallmark: Unopposed oestrogen from chronic anovulation (PCOS, perimenopause); irregular cycles; First-Line Investigation: Serum β \beta β -hCG, TSH, prolactin, androgen profile, OGTT; Primary Clinical Management: Combined oral contraceptives, cyclic progestogens, metformin, letrozole

Endometrial : FIGO Code: AUB-E; Distinguishing Pathophysiological / Imaging Hallmark: Deficient local endometrial vasoconstrictors ( P G F 2 α PGF_{2\alpha} PG F 2 α ​ ) and excessive fibrinolysins; First-Line Investigation: Diagnosis of exclusion; normal ovulatory cycles; Primary Clinical Management: Tranexamic acid, NSAIDs, levonorgestrel IUD ( 52 mg 52\text{ mg} 52 mg )

Iatrogenic : FIGO Code: AUB-I; Distinguishing Pathophysiological / Imaging Hallmark: Drug-induced breakthrough bleeding (anticoagulants, copper IUD, implants); First-Line Investigation: Medication review, rule out pelvic infection; Primary Clinical Management: Adjustment of contraceptive regimen, medical haemostatic support

Not Classified : FIGO Code: AUB-N; Distinguishing Pathophysiological / Imaging Hallmark: Uterine AVM, chronic endometritis, cesarean scar isthmocele; First-Line Investigation: Colour Doppler ultrasound (turbulent high-velocity flow); Primary Clinical Management: Embolisation for AVM (avoid curettage), targeted antibiotic therapy

Current PCOS assessment

In adults, the 2023 international guideline permits AMH as an alternative to ultrasound for defining polycystic ovarian morphology within the diagnostic algorithm, not as a stand-alone screening diagnosis. When ovulatory dysfunction and hyperandrogenism are both present, neither ultrasound nor AMH is needed for diagnosis after alternatives are excluded. Adolescents require both persistent cycle irregularity appropriate to years since menarche and hyperandrogenism; ultrasound and AMH should not be used to diagnose adolescent PCOS. Exclude thyroid disease, hyperprolactinaemia and non-classic congenital adrenal hyperplasia, and assess rapid virilisation for a tumour.

Primary references (checked 7 October 2026): 2023 international PCOS guideline .